Contezolid
Sponsors
Micurx Pharmaceuticals Inc., Beijing Chest Hospital, Bin Cao
Conditions
BoneDiabetic Foot InfectionsJointMeningitisMonotherapyMycobacterium Abscessus InfectionMycobacterium Avium Complex Pulmonary DiseasePulmonary Tuberculosis
Phase 1
Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis
Enrolling by invitationNCT06811025
Start: 2024-02-01End: 2025-12-31Target: 24Updated: 2025-02-06
Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis
Enrolling by invitationNCT06811012
Start: 2024-01-31End: 2025-12-31Target: 24Updated: 2025-02-06
Phase 2
Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults with Moderate or Severe Diabetic Foot Infections
RecruitingCTIS2022-500257-16-00
Start: 2023-03-17Target: 791Updated: 2025-07-15
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort
Active, not recruitingNCT06081361
Start: 2023-12-22End: 2026-12-31Target: 186Updated: 2025-04-01